Disease management
ArteraAI Prostate uses digital pathology images from a patient’s biopsy to predict potential long-term outcomes of their prostate cancer.
The companies will develop AI models trained on real-world data to help identify and diagnose patients with paroxysmal nocturnal hemoglobinuria.
The alliance aims to benefit patients with chronic conditions and allow real-time interoperability among healthcare providers, pharmacies and payers.
The company will use the funds to expand its technology offerings and nationwide partnerships.
Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients when action is advised.
Synchron announced an ALS patient has become the first person to control an iPad using only his thoughts, thanks to a brain-computer interface and Apple’s BCI protocol.
Also, a project developing an AI-powered application for preventing cognitive decline among seniors has won a $2 million grant from the New Zealand government.
Users of XRHealth's immersive therapeutic platform will be able to receive real-time movement analysis feedback during rehabilitation.
The company will utilize the funds to accelerate the development of its clinical diagnostic platform and expand its partnerships with pharmaceutical and biotechnology firms.
The company will use the funds to move into the female health space and increase screening and preventive care.